In melanoma cells knock down of [HDAC6 + HDAC2] or [HDAC6 + HDAC10] significantly enhanced pazopanib lethality whereas knock down of [HDAC6 + HDAC1] or [HDAC6 + HDAC3] were less effective [1]. This evidence concerns the gene HDAC6 and melanoma.